Vias Digital

🌍 The Swiss #biotech sector is set to grow by 15% in 2025. How do companies attract investors? The biotech landscape in #Switzerland is booming, with innovation hubs in Zurich, Basel, and beyond leading the way in precision medicine, AI-driven drug discovery, and sustainability. But in a competitive global market, attracting investors isn’t just about great science - it’s about how you tell your #story. Here are 3 key trends shaping how Swiss biotech companies are adapting their digital strategies to stand out in 2025: 1️⃣ AI-Powered Personalization Investors are flooded with information. Leading biotech companies are turning to AI and data analytics to personalize their messaging and target the right audiences. Predictive analytics help identify high-potential investors. Tailored campaigns simplify complex ideas and make a lasting impact. 2️⃣ Thought Leadership Through Storytelling Innovation is amazing - and #storytelling is what drives connection. Swiss biotech leaders are leveraging LinkedIn, webinars, and events to humanize their breakthroughs and highlight their global impact. The key? Aligning your innovation with societal challenges, like reducing animal testing or advancing personalized medicine. 3️⃣ Evolving Investor Relations The days of in-person roadshows are evolving. Today, companies are also embracing digital investor portals and on-demand video pitches to scale their reach globally. Real-time updates and transparency build trust and engage stakeholders worldwide. This is the new standard for attracting funding in biotech. 💡 What does this mean for you? To capture investor attention in 2025, biotech companies need to: • Simplify complex messaging • Prioritize digital positioning and storytelling • Leverage personalized marketing strategies Are you ready to elevate your digital strategy and stand out? Let’s connect to explore how to make 2025 your strongest year yet! #DigitalMarketing #SocialMediaMarketing #Investors

🧐 Is your healthcare brand strategy as strong as it could be? Now more than ever, companies must juggle digital marketing, thought leadership, lead generation, and crafting compelling narratives for investors, customers and patients. Each element is crucial to your brand’s growth — but which area needs the most attention as soon as possible? 📊 Vote below and let’s see where the focus should be! #HealthcareMarketing #BrandStrategy #InvestorRelations #DigitalTransformation

🚀 How do you humanize innovation in healthcare? In a world where tech-driven solutions are advancing rapidly, healthcare companies often face the challenge of making their brand story resonate with real human experiences. We’ve just published an article on LinkedIn about "Creating a Compelling Brand Story for Healthcare Companies", exploring how to connect technological advancements with real-world benefits — from simplifying complex innovations to sharing patient success stories. Let’s transform your brand story into one that truly connects! #HealthcareInnovation #Storytelling #Branding #MarketingStrategies #DigitalMarketing

Balancing innovation with strict regulatory guidelines is essential for healthcare and biotech startups. Here’s how you can navigate compliance and market effectively. #Marketing #HealthcareInnovation #DigitalMarketing #Switzerland

In Swiss biotech and #healthcare, compliance is not just a box to check — it’s the foundation for building trust and ensuring patient safety. But how do we balance this with the need to innovate with a digital-first approach? With increasing oversight from Swissmedic and the evolution of AI-powered health solutions, companies must push the boundaries of digital marketing while ensuring full compliance with regulations like the Swiss Federal Act on Data Protection. Platforms that automate compliance are emerging as essential tools for staying creative without compromising regulatory standards. Whether it's ensuring all content meets data privacy laws or managing disclaimers automatically, these tools allow for innovation without the risk. As we look ahead, the companies that can innovate while staying compliant in their marketing initiatives will lead the charge in shaping the future of Swiss healthcare. At Vias Digital, we specialize in helping biotech and healthcare companies push the boundaries of digital marketing while staying fully compliant. Our regulatory expertise, combined with data-driven strategies, ensures your brand stands out in a competitive market without compromising compliance. Let’s grow your digital presence the right way! #DigitalMarketing #HealthcareCompliance #BiotechInnovation #SwissBiotech #AIinHealthcare

Switzerland’s biotech sector continues to set the pace in global innovation, attracting major investments and advancing groundbreaking treatments. This week's highlights showcase the sector's momentum: · Oculis is progressing in its Phase 3 DIAMOND program with the non-invasive topical eye drop, OCS-01, designed for Diabetic Macular Edema (DME). This innovation aims to replace more invasive treatments currently in use. The company recently secured $144M in a SPAC deal on NASDAQ and continues its mission of revolutionizing ophthalmology. · Hedera Dx raised €14M to expand its #LiquidBiopsy technology for cancer, offering in-house labs faster DNA analysis for more personalized treatments. · Timeline® secured CHF 56M in Series D funding, backed by L'Oréal and Nestlé, to scale its Mitopure® product, supporting cellular health and longevity. In total, the Swiss Biotech Report 2024 confirms the sector raised CHF 2B+ this year, powered by breakthrough therapies, international partnerships, and a growing innovation ecosystem. With such forward momentum, Swiss biotech companies are not just meeting the challenges of today but shaping the future of global #healthcare. 💡 Is your healthcare or biotech org ready to scale? At Vias Digital, we specialize in regulatory-compliant, data-driven marketing & communications strategies that amplify your impact and help you grow in a competitive landscape. Let’s make your vision a reality. #Biotech #HealthcareInnovation #MarketingStrategy #DigitalMarketing #Switzerland

Compliance is non-negotiable. In healthcare social media, compliance is not just a legal requirement — it's a trust builder. Patients and healthcare professionals expect you to protect their privacy and deliver accurate information. But how do you balance engagement, compliance, and building trust in such a regulated space? ↳ It starts with understanding that HIPAA and GDPR compliance — laws designed to protect privacy in the US and Europe — are foundational to any digital marketing initiative. Avoid sharing information without explicit consent. Always safeguard Protected Health Information (PHI). ↳ Misinformation is another huge risk, especially in healthcare. Inaccurate advice can quickly erode trust. Your content needs to be evidence-based, verified, and credible. Share the facts, not opinions. Compliance doesn’t mean boring. 💡 Use "edutaining" content — mix education with engagement to capture your audience's attention. It keeps them informed, without overwhelming with technical details. The truth is that facts aren’t enough. ↳ Your audience is hungry for interactive, shareable, and relatable content. Think global health campaigns, like World Health Day or Breast Cancer Awareness Month, that connect with larger conversations and build community trust. ↳ And yes, you should include influencers in your strategy. But they must be medically credible — not necessarily popular — so your message stays trusted and authentic. The wrong influencer, or poorly vetted content, can ruin your brand’s hard-earned reputation in a hearbeat. Ensuring your healthcare social media strategy is both compliant and engaging is key to building long-term trust. 📍 Compliance isn’t a limitation — it’s a powerful tool to create a patient-first, value-driven approach that shows transparency and authenticity in every interaction. Let's talk about how Vias Digital, our Swiss-based digital marketing agency for biotech, pharma and healthcare SMEs, can support your #startup! #HealthcareMarketing #SocialMediaStrategy #DigitalMarketing #ReputationManagement

Exciting new research from ETH Zürich! A team led by Sohyon Lee and Berend Snijder has identified an antidepressant with potent anti-glioblastoma activity. Published in Nature Medicine, a Springer Nature journal, the study highlights the potential for repurposing neuroactive drugs to treat aggressive brain tumors. Congrats to co-authors Timo Weiss, Michael Bühler, and all involved in this breakthrough. Read the full study here: https://lnkd.in/g4mfF3Jh 👉 Follow Vias Digital to stay updated on the latest healthcare and biotech news in Switzerland, plus expert tips on marketing and growth strategies for the biotech sector. #DrugResearch #CancerResearch #Biotech #Switzerland

Switzerland’s #biotech sector is experiencing unprecedented momentum, as industry leaders continue to make strategic moves that solidify their standing in the global market. This week’s updates underscore the sector’s strength, driven by cutting-edge innovation, substantial funding rounds, and deepening international collaborations. Here’s our overview of this week's highlights: MoonLake Immunotherapeutics (NASDAQ: MLTX) raised CHF 415M in follow-on financing to accelerate treatments for inflammatory diseases. Alentis Therapeutics secured CHF 105M to advance its cutting-edge research in oncology and fibrosis, cementing its leadership in these critical areas. Noema Pharma continues its mission to address neurological diseases, raising CHF 103M in Series B funding to expand its clinical pipeline. Rejuveron Vascular Therapeutics AG raised CHF 75M in Series B funding, focused on healthy aging and regenerative medicine, an area gaining increasing global attention. CRISPR Therapeutics and Vertex Pharmaceuticals push forward with gene-editing technologies for sickle cell disease, showcasing the power of collaboration in precision medicine. Oculis successfully raised USD 144M via a SPAC deal on NASDAQ, furthering its innovative solutions in ophthalmology. Santhera Pharmaceuticals finalized a CHF 1B acquisition deal with Ironwood Pharma, signaling increased consolidation and focus on neuromuscular and respiratory disease treatments. 🌟 Swiss Startup Spotlight: Amarastesia LTD is pioneering new methods in skin regeneration, leveraging Switzerland’s innovation ecosystem to develop breakthrough therapies. Altiscreen is making waves with its early-stage cancer detection technologies, addressing a critical gap in global healthcare. With CHF 2B+ raised this year and a series of high-impact acquisitions and IPOs, Swiss biotech is poised for continued growth. As we look ahead to 2025, expect these companies to drive innovation and reshape the future of healthcare. 💡 Are you a biotech startup looking to scale? Let’s discuss how Vias Digital can help accelerate your growth with regulatory-compliant, data-driven marketing and communications strategies. #MarketingStrategy #HealthcareInnovation #Marketing #DigitalMarketing #Communications

Data is the currency of growth in #biotech marketing — are you using it? In biotech, data is more than just research. 💡 Did you know that companies using data-driven marketing see a 30% faster growth rate? Yet, many biotech companies leave this potential on the table. Imagine leveraging your data not just in the lab, but in your marketing strategies. Personalized outreach, precise targeting, and optimized campaigns — all powered by real-time insights. But here’s the reality: most biotech startups are so focused on innovation, they miss the opportunity to apply these same principles to their marketing. The result? Missed leads, inefficient campaigns and market positioning, which translate to slower growth. You’ve already invested in generating data—now it’s time to let it work for you. At Vias Digital, we specialize in turning your raw data into actionable marketing strategies that drive measurable results. From personalized campaigns to predictive analytics, we align your marketing with your growth ambitions. Growth is right in front of you. It’s in your data. Are you ready to tap into it? #BiotechMarketing #DataDrivenGrowth #SwissBiotech #DigitalStrategy #MarketingStrategy